Firmoscan
Active08100223Private limited companySalford

ALPHA CLINICAL DEVELOPMENTS LIMITED

B68/100

Owned by Adnan Mahmood and Ashfa Adnan

Companies HouseCompanies House
01

Summary

Generated from filed data · no estimates

ALPHA CLINICAL DEVELOPMENTS LIMITED is an active private limited company (company number 08100223) incorporated on 11 June 2012, registered in Salford. Its registered activity is other research and experimental development on natural sciences and engineering (SIC 72190). Latest micro accounts cover the period ending 30 June 2025, showing net assets of £426k, with 6 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 13% on the prior period (£489k).

Peer position · net assets

By net assets it sits in the top quarter of 178 comparable companies in Manchester (median £1,000, upper quartile £46k).

02

Key dates

Incorporated
11 June 201214 yrs ago
Next accounts due
30 March 2027in 159 days
Confirmation statement due
25 June 2027in 246 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

03

Activity

SIC 72190
Other research and experimental development on natural sciences and engineering
Accounts type
Micro Entity
Size band
MicroCompanies Act thresholds
04

Financials

2 periods on record · latest ending 30 June 2025
Net assets
£426k
−13%vs Jun 2024
Cash at bank
Not reported
Turnover
Not disclosed
Employees
6
+100%vs Jun 2024
Net assets
£426k
Average employees
6
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
30 June 2025£426k——£773k——6
30 June 2024£489k——£847k——3
Current ratio1.49Current assets ÷ creditors within one year

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.

05

Firmoscan score

Rules-based · every point shows its evidence
68 / 100 · grade B
EDCBA
Score breakdown
50Starting scoreEvery scored company starts here
+10Positive net assetsNet assets £425,565 at 2025-06-30
+8EstablishedIncorporated 2012-06-11 (14 years)
68Score, grade B

A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.

06

Ownership and control

2 active · 2 other
  • Dr Adnan Mahmood
    Individual · since 6 April 2016
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • Mrs Ashfa Adnan
    Individual · since 22 December 2022
    • owns 25–50% of shares
    • holds 25–50% of voting rights
    • can appoint or remove directors
  • Mrs Ashfa Adnan
    Individual · since 6 April 2016 · ceased 11 September 2020
    • owns 25–50% of shares
    • holds 25–50% of voting rights
  • Dr Muhammad Aitzaz Ahsan Khan
    Individual · since 11 September 2020 · ceased 22 December 2022
    • owns 25–50% of shares
    • holds 25–50% of voting rights
    • can appoint or remove directors

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.

07

Timeline

Newest first
  1. Confirmation statement duein 246 days
  2. Next accounts duein 159 days
  3. Accounts period endNet assets £426k · micro accounts
  4. Accounts period endNet assets £489k · micro accounts
  5. Incorporated
08

Similar companies in Manchester

Same activity (other research and experimental development on natural sciences and engineering), closest in incorporation date

All companies incorporated on 11 June 2012 · in Jun 2012.

09

Reminders for ALPHA CLINICAL DEVELOPMENTS LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.